Global Injectable Drug Delivery Formulation Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Injectable Drug Delivery Formulation Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Injectable Drug Delivery Formulation by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Injectable Drug Delivery Formulation by Country/Region, 2017, 2022 & 2028

2.2 Injectable Drug Delivery Formulation Segment by Type

2.2.1 Conventional Drug Delivery Formulations

2.2.2 Novel Drug Delivery Formulations

2.2.3 Long-acting Formulations

2.3 Injectable Drug Delivery Formulation Sales by Type

2.3.1 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

2.3.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Type (2017-2022)

2.3.3 Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022)

2.4 Injectable Drug Delivery Formulation Segment by Application

2.4.1 Autoimmune Diseases

2.4.2 Hormonal Disorders

2.4.3 Oncology

2.4.4 Orphan Diseases

2.4.5 Others

2.5 Injectable Drug Delivery Formulation Sales by Application

2.5.1 Global Injectable Drug Delivery Formulation Sale Market Share by Application (2017-2022)

2.5.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Application (2017-2022)

2.5.3 Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022)

3 Global Injectable Drug Delivery Formulation by Company

3.1 Global Injectable Drug Delivery Formulation Breakdown Data by Company

3.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Company (2020-2022)

3.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)

3.2 Global Injectable Drug Delivery Formulation Annual Revenue by Company (2020-2022)

3.2.1 Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022)

3.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)

3.3 Global Injectable Drug Delivery Formulation Sale Price by Company

3.4 Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Injectable Drug Delivery Formulation Product Location Distribution

3.4.2 Players Injectable Drug Delivery Formulation Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Injectable Drug Delivery Formulation by Geographic Region

4.1 World Historic Injectable Drug Delivery Formulation Market Size by Geographic Region (2017-2022)

4.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Injectable Drug Delivery Formulation Annual Revenue by Geographic Region

4.2 World Historic Injectable Drug Delivery Formulation Market Size by Country/Region (2017-2022)

4.2.1 Global Injectable Drug Delivery Formulation Annual Sales by Country/Region (2017-2022)

4.2.2 Global Injectable Drug Delivery Formulation Annual Revenue by Country/Region

4.3 Americas Injectable Drug Delivery Formulation Sales Growth

4.4 APAC Injectable Drug Delivery Formulation Sales Growth

4.5 Europe Injectable Drug Delivery Formulation Sales Growth

4.6 Middle East & Africa Injectable Drug Delivery Formulation Sales Growth

5 Americas

5.1 Americas Injectable Drug Delivery Formulation Sales by Country

5.1.1 Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022)

5.1.2 Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022)

5.2 Americas Injectable Drug Delivery Formulation Sales by Type

5.3 Americas Injectable Drug Delivery Formulation Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Injectable Drug Delivery Formulation Sales by Region

6.1.1 APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022)

6.1.2 APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022)

6.2 APAC Injectable Drug Delivery Formulation Sales by Type

6.3 APAC Injectable Drug Delivery Formulation Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Injectable Drug Delivery Formulation by Country

7.1.1 Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022)

7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022)

7.2 Europe Injectable Drug Delivery Formulation Sales by Type

7.3 Europe Injectable Drug Delivery Formulation Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Injectable Drug Delivery Formulation by Country

8.1.1 Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022)

8.1.2 Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022)

8.2 Middle East & Africa Injectable Drug Delivery Formulation Sales by Type

8.3 Middle East & Africa Injectable Drug Delivery Formulation Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation

10.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation

10.4 Industry Chain Structure of Injectable Drug Delivery Formulation

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Injectable Drug Delivery Formulation Distributors

11.3 Injectable Drug Delivery Formulation Customer

12 World Forecast Review for Injectable Drug Delivery Formulation by Geographic Region

12.1 Global Injectable Drug Delivery Formulation Market Size Forecast by Region

12.1.1 Global Injectable Drug Delivery Formulation Forecast by Region (2023-2028)

12.1.2 Global Injectable Drug Delivery Formulation Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Injectable Drug Delivery Formulation Forecast by Type

12.7 Global Injectable Drug Delivery Formulation Forecast by Application

13 Key Players Analysis

13.1 Becton, Dickinson and Company (US)

13.1.1 Becton, Dickinson and Company (US) Company Information

13.1.2 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered

13.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Becton, Dickinson and Company (US) Main Business Overview

13.1.5 Becton, Dickinson and Company (US) Latest Developments

13.2 Baxter International Inc. (US)

13.2.1 Baxter International Inc. (US) Company Information

13.2.2 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered

13.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Baxter International Inc. (US) Main Business Overview

13.2.5 Baxter International Inc. (US) Latest Developments

13.3 Gerresheimer AG (Germany)

13.3.1 Gerresheimer AG (Germany) Company Information

13.3.2 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered

13.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Gerresheimer AG (Germany) Main Business Overview

13.3.5 Gerresheimer AG (Germany) Latest Developments

13.4 Pfizer, Inc. (US)

13.4.1 Pfizer, Inc. (US) Company Information

13.4.2 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered

13.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer, Inc. (US) Main Business Overview

13.4.5 Pfizer, Inc. (US) Latest Developments

13.5 Schott AG (Germany)

13.5.1 Schott AG (Germany) Company Information

13.5.2 Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered

13.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Schott AG (Germany) Main Business Overview

13.5.5 Schott AG (Germany) Latest Developments

13.6 Sandoz (Germany)

13.6.1 Sandoz (Germany) Company Information

13.6.2 Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered

13.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sandoz (Germany) Main Business Overview

13.6.5 Sandoz (Germany) Latest Developments

13.7 Teva Pharmaceutical Industries Ltd. (Israel)

13.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information

13.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered

13.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Main Business Overview

13.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments

13.8 Eli Lilly and Company (US)

13.8.1 Eli Lilly and Company (US) Company Information

13.8.2 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered

13.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly and Company (US) Main Business Overview

13.8.5 Eli Lilly and Company (US) Latest Developments

14 Research Findings and Conclusion

Table 1. Injectable Drug Delivery Formulation Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Injectable Drug Delivery Formulation Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Conventional Drug Delivery Formulations

Table 4. Major Players of Novel Drug Delivery Formulations

Table 5. Major Players of Long-acting Formulations

Table 6. Global Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

Table 8. Global Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & ($ million)

Table 9. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)

Table 10. Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Table 13. Global Injectable Drug Delivery Formulation Revenue by Application (2017-2022)

Table 14. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2022)

Table 15. Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Injectable Drug Delivery Formulation Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)

Table 18. Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)

Table 20. Global Injectable Drug Delivery Formulation Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution and Sales Area

Table 22. Players Injectable Drug Delivery Formulation Products Offered

Table 23. Injectable Drug Delivery Formulation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Injectable Drug Delivery Formulation Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Injectable Drug Delivery Formulation Sales Market Share Geographic Region (2017-2022)

Table 28. Global Injectable Drug Delivery Formulation Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Injectable Drug Delivery Formulation Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Injectable Drug Delivery Formulation Sales Market Share by Country/Region (2017-2022)

Table 32. Global Injectable Drug Delivery Formulation Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)

Table 36. Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)

Table 38. Americas Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

Table 40. Americas Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Table 42. APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)

Table 44. APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Injectable Drug Delivery Formulation Revenue Market Share by Region (2017-2022)

Table 46. APAC Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

Table 48. APAC Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Table 50. Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)

Table 52. Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)

Table 54. Europe Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

Table 56. Europe Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Injectable Drug Delivery Formulation

Table 67. Key Market Challenges & Risks of Injectable Drug Delivery Formulation

Table 68. Key Industry Trends of Injectable Drug Delivery Formulation

Table 69. Injectable Drug Delivery Formulation Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Injectable Drug Delivery Formulation Distributors List

Table 72. Injectable Drug Delivery Formulation Customer List

Table 73. Global Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Injectable Drug Delivery Formulation Sales Market Forecast by Region

Table 75. Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Injectable Drug Delivery Formulation Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Injectable Drug Delivery Formulation Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Application (2023-2028)

Table 93. Becton, Dickinson and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 94. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered

Table 95. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Becton, Dickinson and Company (US) Main Business

Table 97. Becton, Dickinson and Company (US) Latest Developments

Table 98. Baxter International Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 99. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered

Table 100. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Baxter International Inc. (US) Main Business

Table 102. Baxter International Inc. (US) Latest Developments

Table 103. Gerresheimer AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 104. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered

Table 105. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Gerresheimer AG (Germany) Main Business

Table 107. Gerresheimer AG (Germany) Latest Developments

Table 108. Pfizer, Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 109. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered

Table 110. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Pfizer, Inc. (US) Main Business

Table 112. Pfizer, Inc. (US) Latest Developments

Table 113. Schott AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 114. Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered

Table 115. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Schott AG (Germany) Main Business

Table 117. Schott AG (Germany) Latest Developments

Table 118. Sandoz (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 119. Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered

Table 120. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Sandoz (Germany) Main Business

Table 122. Sandoz (Germany) Latest Developments

Table 123. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 124. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered

Table 125. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Teva Pharmaceutical Industries Ltd. (Israel) Main Business

Table 127. Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments

Table 128. Eli Lilly and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors

Table 129. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered

Table 130. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Eli Lilly and Company (US) Main Business

Table 132. Eli Lilly and Company (US) Latest Developments

List of Figures

Figure 1. Picture of Injectable Drug Delivery Formulation

Figure 2. Injectable Drug Delivery Formulation Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Injectable Drug Delivery Formulation Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Injectable Drug Delivery Formulation Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Injectable Drug Delivery Formulation Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Conventional Drug Delivery Formulations

Figure 10. Product Picture of Novel Drug Delivery Formulations

Figure 11. Product Picture of Long-acting Formulations

Figure 12. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2021

Figure 13. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)

Figure 14. Injectable Drug Delivery Formulation Consumed in Autoimmune Diseases

Figure 15. Global Injectable Drug Delivery Formulation Market: Autoimmune Diseases (2017-2022) & (K Pcs)

Figure 16. Injectable Drug Delivery Formulation Consumed in Hormonal Disorders

Figure 17. Global Injectable Drug Delivery Formulation Market: Hormonal Disorders (2017-2022) & (K Pcs)

Figure 18. Injectable Drug Delivery Formulation Consumed in Oncology

Figure 19. Global Injectable Drug Delivery Formulation Market: Oncology (2017-2022) & (K Pcs)

Figure 20. Injectable Drug Delivery Formulation Consumed in Orphan Diseases

Figure 21. Global Injectable Drug Delivery Formulation Market: Orphan Diseases (2017-2022) & (K Pcs)

Figure 22. Injectable Drug Delivery Formulation Consumed in Others

Figure 23. Global Injectable Drug Delivery Formulation Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)

Figure 25. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2021

Figure 26. Injectable Drug Delivery Formulation Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Company in 2021

Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region in 2021

Figure 30. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)

Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region in 2021

Figure 32. Americas Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)

Figure 33. Americas Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)

Figure 34. APAC Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)

Figure 35. APAC Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)

Figure 36. Europe Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)

Figure 37. Europe Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)

Figure 40. Americas Injectable Drug Delivery Formulation Sales Market Share by Country in 2021

Figure 41. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021

Figure 42. United States Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Injectable Drug Delivery Formulation Sales Market Share by Region in 2021

Figure 47. APAC Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2021

Figure 48. China Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2021

Figure 55. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021

Figure 56. Germany Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021

Figure 63. Egypt Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation in 2021

Figure 69. Manufacturing Process Analysis of Injectable Drug Delivery Formulation

Figure 70. Industry Chain Structure of Injectable Drug Delivery Formulation

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles